Detalhe da pesquisa
1.
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and China.
Eur Arch Psychiatry Clin Neurosci
; 2024 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38462586
2.
Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia.
Eur Arch Psychiatry Clin Neurosci
; 272(4): 603-619, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34822007
3.
Inflammatory processes linked to major depression and schizophrenic disorders and the effects of polypharmacy in psychiatry: evidence from a longitudinal study of 279 patients under therapy.
Eur Arch Psychiatry Clin Neurosci
; 271(3): 507-520, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32696276
4.
Analysis of genetic diversity in patients with major psychiatric disorders versus healthy controls: A molecular-genetic study of 1698 subjects genotyped for 100 candidate genes (549 SNPs).
Psychiatry Res
; 333: 115720, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38224633